These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 402107)

  • 41. Immune modulating effects of poly ICLC.
    Levy HB; Lvovsky E; Riley F; Harrington D; Anderson A; Moe J; Hilfenhaus J; Stephen E
    Ann N Y Acad Sci; 1980; 350():33-41. PubMed ID: 6972185
    [No Abstract]   [Full Text] [Related]  

  • 42. Role of xanthine oxidase in the interferon-mediated depression of the hepatic cytochrome P-450 system in mice.
    Mannering GJ; Deloria LB; Abbott V
    Cancer Res; 1988 Apr; 48(8):2107-12. PubMed ID: 2450644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon induction and therapy of brain tumors in rats by poly(ICLC).
    Machida H; Takezawa J; Kuninaka A; Yoshino H; Nakamura O; Takakura K
    Microbiol Immunol; 1982; 26(4):353-8. PubMed ID: 6180284
    [No Abstract]   [Full Text] [Related]  

  • 44. [Influence of a complex of poly(I). poly(C) and poly-l-lysine on the course of vaccinia in monkeys].
    Andzhaparidze OG; Bektemirov TA; Burgasova MP
    Vopr Virusol; 1977; (3):339-43. PubMed ID: 410162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
    Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
    No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical studies of an interferon inducer, polyriboinosinic-polyribocytidylic acid [poly (I)-poly (C)], in children.
    Guggenheim MA; Baron S
    J Infect Dis; 1977 Jul; 136(1):50-8. PubMed ID: 328786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical polyriboinosinic-polyribocytidylic acid complex in the treatment of recurrent genital herpes.
    Crane LR; Levy HB; Lerner AM
    Antimicrob Agents Chemother; 1982 Mar; 21(3):481-5. PubMed ID: 7049075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.
    Baer GM; Moore SA; Shaddock JH; Levy HB
    Bull World Health Organ; 1979; 57(5):807-13. PubMed ID: 120234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
    Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
    Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Historical overview of the use of polynucleotides in cancer.
    Levy HB
    J Biol Response Mod; 1985 Oct; 4(5):475-80. PubMed ID: 2416882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poly ICLC induces anti-IC antibodies in mice and rabbits.
    Granados EN; Alm T; O'Malley JA; McGarry M; Bello J
    J Interferon Res; 1984; 4(1):57-62. PubMed ID: 6715915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity.
    DeCicco KL; Youngdahl JD; Ross AC
    Immunology; 2001 Nov; 104(3):341-8. PubMed ID: 11722649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feline interferon response to 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166).
    Stringfellow DA; Weed Sd
    Am J Vet Res; 1977 Dec; 38(12):1963-7. PubMed ID: 596695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Susceptibility of various cells treated with interferon to the toxic effect of poly(rI).poly(rC) treatment.
    Emeny JM; Morgan MJ
    J Gen Virol; 1979 Apr; 43(1):253-5. PubMed ID: 113495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-stranded RNA regulation of DNA synthesis in fibroblasts.
    Perricone MA; Giri SN; Hyde DM
    Exp Cell Res; 1992 Jan; 198(1):101-6. PubMed ID: 1727043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
    Kende M
    J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys.
    Kende M; Paragas J; Salazar AM
    Antiviral Res; 2019 Mar; 163():179-184. PubMed ID: 30611774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel antiviral therapeutics to control foot-and-mouth disease.
    Dias CC; Moraes MP; Weiss M; Diaz-San Segundo F; Perez-Martin E; Salazar AM; de los Santos T; Grubman MJ
    J Interferon Cytokine Res; 2012 Oct; 32(10):462-73. PubMed ID: 22924938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulation of hematopoietic stem cells by interferon inducer in nonhuman primates receiving fractionated total body irradiation.
    Lvovsky EA; Levine PH; Bengali Z; Leiseca SA; Cicmanec JL; Robinson JE; Bautro N; Levy HB; Scott RM
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1721-6. PubMed ID: 6759479
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.